Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase EARLY_PHASE1 1Phase 1/2 1

Status

Completed 4Suspended 1Recruiting 1

Sponsor Class

OTHER 6INDUSTRY 1FED 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1

Conditions

Breast Neoplasms 2315Neoplasms 1678Prostatic Neoplasms 1178Lung Neoplasms 908Colorectal Neoplasms 873Carcinoma, Non-Small-Cell Lung 848Leukemia, Myeloid, Acute 587Pancreatic Neoplasms 568Multiple Myeloma 542Carcinoma, Hepatocellular 510Brain Neoplasms 509Neoplasm Metastasis 456Head and Neck Neoplasms 454Melanoma 410Ovarian Neoplasms 404Glioblastoma 397Precursor Cell Lymphoblastic Leukemia-Lymphoma 390Stomach Neoplasms 370Uterine Cervical Neoplasms 355Squamous Cell Carcinoma of Head and Neck 355Rectal Neoplasms 336Recurrence 332Hematologic Neoplasms 323Sarcoma 322Colonic Neoplasms 316Lymphoma 310Triple Negative Breast Neoplasms 284Urinary Bladder Neoplasms 279Glioma 277Carcinoma, Renal Cell 277

Interventions

sodium thiosulfate 1Vorinostat 1Hydroxymethylglutaryl-CoA Reductase Inhibitors 1Hearing Tests 1Genetic Association Studies 1Cisplatin 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × Ototoxicity × 1 year × Clear all
NCT06036407 2026-04-14

HEAR

University of Bern

Phase NA Completed
476 enrolled

Ototoxicity, Neoplasms, Hearing Loss

NCT06553157 2026-01-20

Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy

Minia University

Phase 1/2 Completed
56 enrolled

Ototoxicity

NCT05789316 2026-01-12

Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)

Washington University School of Medicine

Phase NA Completed
55 enrolled
Head & Neck

Ototoxicity, Head and Neck Neoplasms, Hearing Loss

NCT02425397 2025-12-01

OTOPLAT

Assistance Publique - Hôpitaux de Paris

Completed
119 enrolled

Ototoxicity, Neoplasms, Hearing Loss

NCT05936034 2025-11-28

PROTOTOX

Institut de Cancérologie de Lorraine

Phase NA Recruiting
52 enrolled

Ototoxicity, Hearing Disorders, Neoplasms

NCT05756660 2025-10-20

Sodium Thiosulfate Otoprotection During Salvage Cisplatin Therapy

Children's Hospital Medical Center, Cincinnati

Phase EARLY_PHASE1 Suspended
33 enrolled
Gastrointestinal

Ototoxicity, Neoplasms, Germ Cell and Embryonal, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡